Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Status:
Completed
Trial end date:
2018-10-15
Target enrollment:
Participant gender:
Summary
This clinical study will evaluate whether taking an investigational drug called exendin 9-39
is safe, well-tolerated, and helps to prevent low blood sugar in people who have had
bariatric surgery and later develop a rare condition called postbariatric hypoglycemia (PBH).